| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |